Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Illumina Inc (NASDAQ:ILMN)

205.62
Delayed Data
As of 3:59pm ET
 -0.86 / -0.42%
Today’s Change
119.37
Today|||52-Week Range
214.34
+60.59%
Year-to-Date

Today’s Trading

Previous close206.48
Today’s open207.98
Day’s range205.30 - 207.99
Volume470,664
Average volume (3 months)873,950
Market cap$30.2B
Dividend yield--
Data as of 3:59pm ET, 10/18/2017

Growth & Valuation

Earnings growth (last year)-0.97%
Earnings growth (this year)+9.55%
Earnings growth (next 5 years)+14.43%
Revenue growth (last year)+8.05%
P/E ratio41.2
Price/Sales7.90
Price/Book13.74

Competitors

----
BIVVBioverativ Inc-0.11-0.18%
EXASExact Sciences Corp+0.13+0.28%
BLUEbluebird bio Inc-1.10-0.78%
Data as of 3:59pm ET, 10/18/2017

Financials

Next reporting dateOctober 24, 2017
EPS forecast (this quarter)$0.99
Annual revenue (last year)$2.4B
Annual profit (last year)$454.1M
Net profit margin18.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Francis A. deSouza
Executive VP-Operations, Products &
Strategy
Ostadan Omead
Corporate headquarters
San Diego, California

Forecasts